Table 2.
Associations between clinical characteristics and all-cause mortality among women diagnosed with ovarian cancer.
| Characteristics | No. of Deaths/Total (%) | Adjusted HR a (95% CI) |
|---|---|---|
| Age at diagnosis | ||
| ≤50 | 43/246 (17.48) | 1.00 (ref) |
| >50 | 80/423 (18.91) | 1.19 (0.82, 1.74) |
| Histological type | ||
| Serous | 88/458 (19.21) | 1.00 (ref) |
| Non-serous | 35/211 (16.59) | 1.69 (1.07, 2.66) |
| Histopathologic grade | ||
| Poorly differentiated | 112/569 (19.68) | 1.00 (ref) |
| Moderately differentiated | 7/48 (14.58) | 0.66 (0.30, 1.48) |
| Well differentiated | 4/52 (7.69) | 0.49 (0.18, 1.36) |
| FIGO stage | ||
| Ⅰ–Ⅱ | 39/335 (11.64) | 1.00 (ref) |
| Ⅲ–Ⅳ | 84/312 (26.92) | 2.73 (1.75, 4.26) |
| Residual lesions | ||
| No | 77/523 (14.72) | 1.00 (ref) |
| ≤1 cm | 30/104 (28.85) | 1.66 (1.06, 2.60) |
| >1 cm | 16/42 (38.10) | 2.33 (1.32, 4.09) |
| Comorbidities | ||
| No | 69/367 (18.80) | 1.00 (ref) |
| Yes | 54/302 (17.88) | 0.97 (0.67, 1.39) |
CI, confidence interval; FIGO, The International Federation of Gynecology and Obstetrics; HR, hazard ratio; Ref, reference. HR and 95% CI were calculated with the use of the Cox proportional hazards regression model. a Mutually adjusted for all other variables listed in the table.